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Background: Great biodiversity is a highlight of Brazilian flora. In contrast, the therapeutic potentialities of most
species used in folk medicine remain unknown. Several of these species are commonly used to treat cancer. In this
study, we investigated the cytotoxic activity of 18 plants from 16 families that are found in the northeast region of
Brazil.
Methods: The following species were studied: Byrsonima sericea DC. (Malpighiaceae), Cupania impressinervia Acev.
Rodr. var. (revoluta) Radlk (Sapindaceae), Duranta repens Linn. (Verbenaceae), Helicostylis tomentosa (Poepp. & Endl)
Rusby (Moraceae), Himatanthus bracteatus (A.DC.) Woodson (Apocynaceae), Ipomoea purga (Wender.) Hayne
(Convolvulaceae), Ixora coccinea Linn. (Rubiaceae), Mabea piriri Aubl. (Euphorbiaceae), Miconia minutiflora
(Melastomataceae), Momordica charantia L. (Cucurbitaceae), Ocotea glomerata (Nees) Mez (Lauraceae), Ocotea
longifolia Kunth (Oreodaphne opifera Mart. Nees) (Lauraceae), Pavonia fruticosa (Mill.) Fawc. & Rendle (Malvaceae),
Psychotria capitata Ruiz & Pav. (Rubiaceae), Schefflera morototoni (Aubl.) Maguire, Steyerm. & Frodin (Araliaceae),
Solanum paludosum Moric. (Solanaceae), Xylopia frutescens Aubl. (Annonaceae) and Zanthoxylum rhoifolium Lam.
(Rutaceae). Their dried leaves, stems, flowers or fruits were submitted to different solvent extractions, resulting in
55 extracts. After incubating for 72 h, the cytotoxicity of each extract was tested against tumor cell lines using the
alamar blue assay.
Results: The B. sericea, D. repens, H. bracteatus, I. purga, I. coccinea, M. piriri, O. longifolia and P. capitata extracts
demonstrated the most potent cytotoxic activity. The chloroform soluble fractions of D. repens flowers and the
hexane extract of I. coccinea flowers led to the isolation of quercetin and a mixture of α- and β-amyrin, respectively,
and quercetin showed moderate cytotoxic activity.
Conclusion: The B. sericea, D. repens, H. bracteatus, I. purga, I. coccinea, M. piriri, O. longifolia and P. capitata plants were
identified as having potent cytotoxic effects. Further investigations are required to determine the mechanisms of
cytotoxicity exhibited and their in vivo activities. This work reinforces the need to understand the therapeutics
potentialities of Brazilian medicinal plants.
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In Brazil, the estimated number of described plant spe-
cies (terrestrial and algae) ranges from 50,542 to 60,042
[1]; they are found in the following six different biomes:
Amazônia (the Amazon rainforest in northern and
central-western Brazil), Cerrado (the central Brazilian
savanna), Mata Atlântica (the Atlantic rainforest ranging
from sea level to the eastern highlands of Brazil), Caatinga
(a xerophilous thorny forest found in northeastern Brazil),
Pampa (the grasslands in southern Brazil) and Pantanal
(periodically flooded grasslands by the Paraná and
Paraguay rivers in central-western Brazil). Thus, Brazil is
one of the most biodiverse nations in the world [1–3].
The cytotoxic potential of some Brazilian medicinal
plants has been previously investigated [4–7]; however,
due to the country’s great biodiversity, the therapeutic
potentialities of most species remain unknown. In this
work, the cytotoxic activities of 18 plants belonging to
16 families found in northeast Brazil were assessed
against tumor cell lines. The following species were
studied: Byrsonima sericea DC. (Malpighiaceae), Cupa-
nia impressinervia Acev. Rodr. var. (revoluta) Radlk
(Sapindaceae), Duranta repens Linn. (Verbenaceae),
Helicostylis tomentosa (Poepp. & Endl) Rusby (Moraceae),
Himatanthus bracteatus (A.DC.) Woodson (Apocyna-
ceae), Ipomoea purga (Wender.) Hayne (Convolvulaceae),
Ixora coccinea Linn. (Rubiaceae), Mabea piriri Aubl.
(Euphorbiaceae), Miconia minutiflora (Melastomataceae),
Momordica charantia L. (Cucurbitaceae), Ocotea glomer-
ata (Nees) Mez (Lauraceae), Ocotea longifolia Kunth
(Oreodaphne opifera Mart. Nees) (Lauraceae), Pavonia
fruticosa (Mill.) Fawc. & Rendle (Malvaceae), Psychotria
capitata Ruiz & Pav. (Rubiaceae), Schefflera morototoni
(Aubl.) Maguire, Steyerm. & Frodin (Araliaceae), Solanum
paludosum Moric. (Solanaceae), Xylopia frutescens
Aubl. (Annonaceae) and Zanthoxylum rhoifolium
Lam. (Rutaceae). The plant species, family, vernacu-




Leaves, stems, fruits and/or flowers of B. sericea (vou-
cher number 45628), C. impressinervia (voucher number
42953), D. repens (voucher number 25870), H. tomentosa
(voucher number 20586), H. bracteatus (voucher num-
ber 50733), I. purga (voucher number 33255) and I.
coccinea (voucher number 25861) were collected in
February 2014 in the Municipality of Viçosa, Alagoas,
Brazil. Leaves and/or stems of M. piriri (voucher num-
ber 45717), M. minutiflora (voucher number 49653), M.
charantia (voucher number 34393), O. glomerata (vou-
cher number 50577), O. longifolia (voucher number
50577), P. fruticosa (voucher number 45659) and P.capitata (voucher number 45620) were collected in
March 2014 in the municipality of Rio Largo, Alagoas,
Brazil. Leaves, stems and/or fruits of S. morototoni (vou-
cher number 45659), S. paludosum (voucher number
37400), X. frutescens (voucher number 45677) and Z.
rhoifolium (voucher number 49656) were collected in
March 2014 in the Municipality of Murici, Alagoas,
Brazil. All plants were collected in the Mata Atlântica
bioma. The species were identified by Rosângela Pereira
e Lyra Lemos, a plant taxonomist from the Instituto do
Meio Ambiente de Alagoas IMA-AL. Voucher botanical
specimens are stored at the Herbarium of the Instituto
do Meio Ambiente de Alagoas IMA-AL. This work was
performed according to the special authorization for ac-
cess to genetic resources in Brazil # 010344/2014-4, is-
sued by CNPq/MCTI.
Plant extractions
The dried leaves, stems, flowers or fruits were triturated
and extracted at room temperature with ethanol or
hexane. The solvent was removed to produce the
correspondent crude extracts. The extraction steps for
each sample were repeated three times with one-week
intervals. Part of leaves, fruits or flowers ethanol extract
was suspended in methanol:water (9:1) solution and
extracted successively with ethyl acetate, chloroform,




Purification processes were performed through column
chromatography (CC) using silica gel 60 (0.063-
0.200 mm) as the stationary phase. Organic solvents or
mixtures of increasing polarity were used as mobile
phases. Silica gel 60 GF (Merck, Darmstadt, Germany)
was used to perform analytical (0.25 mm) or preparative
(0.75 mm) thin layer chromatographic (TLC) processes.
The 1H (400 MHz) and 13C (100 MHz) nuclear mag-
netic resonance (NMR) spectra were obtained on a Bruker
Avance DRX-400 spectrometer (Bruker, Rheinstetten,
Germany), operating at 300 K. The chemical shifts (δ)
were expressed in units of ppm, using tetramethylsilane
(TMS) as a reference (δH = δc = 0), and the coupling con-
stants (J) were expressed in Hz. Chloroform-d was used as
the solvent for the samples.
Isolation of compounds
The chloroform extract of D. repens flowers (7 g) was
submitted to silica gel CC eluted with hexane and ethyl
acetate (either pure or a mixture of increasing polarity),
providing 50 fractions (5 mL each) that were grouped
with hexane and ethyl acetate. After solvent evaporation,
fractions 30–50 were purified with Sephadex-L
Table 1 List of plants and their vernacular name and folk use in Brazil
Plant species Family Vernacular name Folk use in Brazil
Byrsonima sericea DC. Malpighiaceae Murici-da-mata A decoction of the stem-bark is used to treat fevers, diarrhea,
syphilis and kidney disease [26]
Cupania impressinervia Acev.
Rodr. var. (revoluta) Radlk
Sapindaceae Caboatã-de-rego -
Duranta repens Linn. Verbenaceae Pingo-de-ouro Ornamental [27]
Helicostylis tomentosa (Poepp.
& Endl) Rusby
Moraceae Amoreira-preta Its fruit is used as a nutritional source [28]
Himatanthus bracteatus
(A.DC.) Woodson
Apocynaceae Janaguba The latex is topically applied to treat external ulcers and tumors. It is
dropped in a liter of water against inflammation and cancer [26]
Ipomoea purga (Wender.)
Hayne
Convolvulaceae Jalapa, batata-de-purga It is used as an analgesic [29]
Ixora coccinea Linn. Rubiaceae Ixora Ornamental [30]
Mabea piriri Aubl. Euphorbiaceae Canudo de cachimbo -
Miconia minutiflora Melastomataceae Mundururu Its fruit is used as a nutritional source [28]
Momordica charantia L. Cucurbitaceae Melão-de-sabiá, melão-de-
são-caetano, galinha-de-
melão
A decoction of a handful in a liter of water is used as a tea to treat
diabetes, parasite infections, rheumatism and diarrhea [26]
Ocotea glomerata (Nees) Mez Lauraceae Caneleira, louro-branco,
louro-abacate, louro-bravo
The leaves are used to treat hydropsy, digestive problems and high




Lauraceae Canela de cheiro Fruit oil is used to treat arthralgia and rheumatic diseases [33]
Pavonia fruticosa (Mill.) Fawc.
& Rendle
Malvaceae - -
Psychotria capitata Ruiz & Pav. Rubiaceae - -
Schefflera morototoni (Aubl.)
Maguire, Steyerm. & Frodin
Araliaceae Matatauba, Marupá Its fruit is used as a nutritional source and to make local crafts [28]
Solanum paludosum Moric. Solanaceae Jurubeba-brava, jurubeba-
roxa
An infusion of the roots is used to treat hepatic diseases. The fruit is
used as a poison [26]
Xylopia frutescens Aubl. Annonaceae Embira, semente-de-
embira
Its seeds and fruits are used as a digestive aid (a decoction of a
teaspoon in a cup of water). It is used as a tea after meals [26]
Zanthoxylum rhoifolium Lam. Rutaceae Mamica de cadela, mamica
de porca
The roots are used as a febrifuge, digestant and tonic. The stem bark
is used to treat flatulence, colic, dyspepsia, ear aches, toothaches and
snake bites [34]
da Silva et al. BMC Complementary and Alternative Medicine  (2016) 16:199 Page 3 of 9water:methanol, yielding the compound quercetin
(56, 11.0 mg). The compound structure was identi-
fied through a series of spectrometric data, such as
NMR, as well as by comparison with data reported
in the literature.
A hexane extract of I. coccinea flowers (26 g) was
submitted to silica gel CC eluted with hexane, ethyl
acetate and methanol (either pure or a mixture of in-
creasing polarity), providing 100 fractions (5 mL each)
that were grouped with hexane, ethyl acetate and
methanol. After solvent evaporation from fractions 30
to 45 (eluted with hexane/ethyl acetate 8:2), a white
solid (in the form of flakes) was obtained (57,
14.0 mg). This solid was identified as a mixture of α-
and β-amyrin. The compounds structures were identi-
fied through a series of spectrometric data, such as
NMR, as well as by comparison with data reported in
the literature.Cells
Tumor cells lines B16-F10 (mouse melanoma), HepG2
(human hepatocellular carcinoma), K562 (human
chronic myelocytic leukemia) and HL-60 (human pro-
myelocytic leukemia) were donated by the Hospital A.C.
Camargo, São Paulo, SP, Brazil. This panel of cell lines
include different types of cell histology with different
sensibility. Cells were maintained in Roswell Park Me-
morial Institute-1640 (RPMI-1640, Gibco-BRL, Gaithers-
burg, USA) medium supplemented with 10 % fetal
bovine serum (Cultilab, Campinas, Brazil), 2 mM L-glu-
tamine (Vetec Química Fina, Duque de Caxias, Brazil)
and 50 μg/mL gentamycin (Novafarma, Anápolis, Brazil).
Adherent cells were harvested by treatment with 0.25 %
trypsin EDTA solution (Gibco-BRL, Gaithersburg, USA).
All cell lines were cultured in cell culture flasks at 37 °C
in 5 % CO2 and sub-cultured every 3–4 days to maintain
exponential growth. All experiments were conducted
Table 2 Growth inhibitory effects of plant extracts/fractions against tumor cell lines
No. Plant species Parts of the planta
(Extractionsb)
Cellc growth inhibition percentage (GI %)d
HepG2 HL60
01 Byrsonima sericea DC. F (e) 25.03 ± 5.24 25.27 ± 8.79
02 S (e) 8.02 ± 6.85 27.32 ± 0.06
03 L (e) 21.84 ± 2.64 64.71 ± 5.28
04 L (m/e) 91.16 ± 0.64 102.7 ± 1.12
05 L (ea/e) 92.14 ± 0.64 103.3 ± 7.26
06 L (c/e) 39.96 ± 9.49 70.12 ± 11.24
07 L (h/e) 91.62 ± 0.39 109.0 ± 2.52
08 Cupania impressinervia Acev. Rodr. var. (revoluta) Radlk L (e) 23.10 ± 5.59 55.19 ± 5.50
09 Duranta repens Linn. FL (m/e) 14.09 ± 7.14 33.3 ± 0.92
10 FL (ea/e) 20.57 ± 7.67 28.36 ± 0.46
11 FL (c/e) 79.94 ± 2.97 98.67 ± 6.35
12 Helicostylis tomentosa (Poepp. & Endl) Rusby S (e) 14.55 ± 3.30 53.67 ± 0,58
13 L (e) 7.96 ± 3.56 38.39 ± 7.33
14 Himatanthus bracteatus (A.DC.) Woodson S (e) 20.55 ± 1.61 29.38 ± 1.63
15 L (e) −9.90 ± 6.56 −16.91 ± 4.61
16 L (h) 14.78 ± 5.22 70.63 ± 2.62
17 L (m/e) −0.77 ± 2.61 28.55 ± 3.25
18 L (ea/e) 5.70 ± 2.61 56.16 ± 9.49
19 L (c/e) 92.30 ± 1.50 93.63 ± 0.30
20 Ipomoea purga (Wender.) Hayne S (e) 98.39 ± 1.81 95.58 ± 1.33
21 L (e) 93.86 ± 2.70 106.4 ± 3.62
22 Ixora coccinea Linn. F (e) −2.97 ± 9.22 1.27 ± 3.86
23 FL (h) 21.47 ± 5.44 −25.64 ± 9.33
24 L (m/e) 9.25 ± 4.73 1.38 ± 1.35
25 L (ea/e) 7.49 ± 5.16 32.25 ± 9.39
26 L (h/e) 22.55 ± 3.23 58.78 ± 1.34
27 F (ea/e) −5.53 ± 7.07 18.83 ± 5.74
28 F (c/e) 94.93 ± 0.74 92.97 ± 2.39
29 Mabea piriri Aubl. S (e) 81.41 ± 8.27 92.35 ± 7.66
30 L (e) 12.48 ± 5.12 69.56 ± 0.17
31 Miconia minutiflora S (e) 25.64 ± 6.34 38.17 ± 1.16
32 L (e) 38.62 ± 2.72 66.54 ± 0.85
33 Momordica charantia L. L (e) −17.51 ± 2.97 9.30 ± 5.64
34 Ocotea glomerata (Nees) Mez S (e) 49.49 ± 9.87 32.70 ± 9.32
35 L (c/e) 25.48 ± 7.87 52.0 ± 3.12
36 Ocotea longifolia Kunth (Oreodaphne opifera Mart. Nees) S (e) −7.43 ± 5.88 2.49 ± 0.33
37 L (e) 93.88 ± 2.12 94.70 ± 1.06
38 Pavonia fruticosa (Mill.) Fawc. & Rendle S (e) 44.81 ± 1.66 41.65 ± 6.51
39 L (e) 33.34 ± 4.48 55.82 ± 4.66
40 Psychotria capitata Ruiz & Pav. S (e) 15.82 ± 3.12 64.16 ± 0.32
41 L (e) 28.13 ± 8.45 22.00 ± 5.92
42 L (m/e) 19.16 ± 8.90 51.72 ± 4.86
43 L (ea/e) 95.14 ± 1.83 86.55 ± 4.20
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44 L (c/e) 96.92 ± 1.68 92.87 ± 0.06
45 L (h/e) 12.28 ± 4.71 −26.37 ± 1.89
46 L (h:ea/e) 61.84 ± 9.74 48.62 ± 1.18
47 Schefflera morototoni (Aubl.) Maguire, Steyerm. & Frodin S (e) 42.73 ± 1.59 −23.89 ± 3.53
48 L (e) 9.05 ± 7.07 63.74 ± 8.13
49 Solanum paludosum Moric. S (e) 17.69 ± 5.22 63.81 ± 2.08
50 Xylopia frutescens Aubl. S (e) 19.36 ± 3.74 72.39 ± 2.90
51 L (m/e) 29.88 ± 2.90 18.19 ± 6.52
52 L (ea/e) 19.46 ± 7.46 51.24 ± 5.86
53 L (c/e) 71.00 ± 3.06 62.71 ± 4.30
54 L (h/e) 23.49 ± 3.57 69.41 ± 0.88
55 Zanthoxylum rhoifolium Lam. L (e) 15.53 ± 5.03 14.00 ± 4.00
Doxorubicine 85.20 ± 0.78 86.34 ± 2.27
aParts of the plant: L leaves, S stem, F Fruits, FL flowers
bExtractions: h hexane, m methanol, e ethanol, m/e methanol/water partition from the ethanolic extract, ea/e ethyl acetate partition from the ethanolic extract,
h/e hexane partition from the ethanolic extract, c/e chloroform partition from the ethanolic extract, h:ea/e, hexane:ethyl acetate (1:1) partition from the
ethanolic extract
cCell lines: HepG2 (human hepatocellular carcinoma) and HL60 (human promyelocytic leukemia)
dGI % values are presented as the mean ± S.E.M. of two independents experiment performed in triplicate measured by the alamar blue assay after 72 h
incubation. All extracts were tested at a concentration of 50 μg/mL. The negative control received the vehicle used to dilute the tested samples (0.5 % DMSO)
eDoxorubicin was used as the positive control
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were tested for mycoplasma with a Mycoplasma Stain
Kit (Sigma-Aldrich, St Louis, MO, USA) and found to
be free from contamination.
Heparinized blood (from healthy, 20- to 35-year-old,
non-smoking donors who had not taken any drug for at
least 15 days prior to the sampling) was collected, and
peripheral blood mononuclear cells (PBMC) were iso-
lated using a standard protocol, with Ficoll (Ficoll-Paque
Plus, GE Healthcare Bio-Sciences AB, Sweden) density
gradient centrifugation. PBMC were washed and resus-
pended at a concentration of 0.3 × 106 cells/mL in RPMI
1640 medium supplemented with 20 % fetal bovine
serum, 2 mM L-glutamine, and 50 μg/mL gentamycin at
37 °C with 5 % CO2. In addition, concanavalin A (ConA,
Sigma Chemical Co. St Louis, MO, USA) was used as a
mitogen to trigger cell division in T-lymphocytes. ConA
(10 μg/mL) was added at the beginning of the culture,
and after 24 h, the cells were treated with the test drugs.
For all experiments, cell viability was examined using
Trypan blue exclusion assays. Over 90 % of the cells
were viable at the beginning of the culture.
Cytotoxicity assay
Cell viability was quantified using alamar blue assay, as
previously described [8]. For all experiments, cells were
seeded in 96-well plates (0.7 × 105 cells/mL for adherent
cells or 0.3 × 106 cells/mL for suspended cells in 100 μL
of medium). After 24 h (or immediately for the sus-
pended cells), the samples, which were dissolved indimethyl sulfoxide (DMSO, Sigma-Aldrich, St Louis,
MO, USA) at a final concentration of 50 μg/mL, were
added to each well and incubated for 72 h. Doxorubicin
(purity >95 %, Laboratórios IMA S.A.I.C., Buenos Aires,
Argentina) was used as the positive control. The nega-
tive control received the vehicle used to dilute the tested
samples (0.5 % DMSO). Four (for cell lines) or 24 h (for
PBMC) before the end of the incubation, 20 μL of stock
solution (0.312 mg/mL) of the alamar blue (resazurin,
Sigma-Aldrich, St Louis, MO, USA) were added to each
well. The absorbance was measured using a SpectraMax
190 microplate reader (Molecular Devices, Sunnyvale,
USA), and the drug effect was quantified as the percent-
age of control absorbance at 570 and 600 nm. The ex-
tracts that caused more than 75 % cell growth inhibition
were tested again at concentrations varying from 0.39 to
50 μg/mL to determine the 50 % inhibitory concentra-
tion (IC50). Isolated compounds were tested at concen-
trations varying from 0.19 to 25 μg/mL.
Statistical analysis
Data are presented as the mean ± S.E.M. The IC50 values
were obtained through nonlinear regression using the
GraphPad program (Intuitive Software for Science, San
Diego, USA).
Results and discussion
Fifty-five extracts were obtained from the plants studied,
and their cytotoxicities were tested using the alamar blue
assay after 72 h of incubation. The cytotoxicity of each
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(HepG2 and HL-60) at a final concentration of
50 μg/mL. The plant species and plant parts/solvent
used for extract preparation are shown in Table 2.
Concentration-response curves were generated and IC50
values were calculated against four tumor cell lines
(B16-F10, HepG2, K562 and HL-60) and against oneTable 3 IC50 values of plant extracts/fractions and isolated compoun
No. Plant species Parts of planta
(Extractionsb)
04 Byrsonima sericea DC. L (m/e)
05 L (ea/e)
07 L (h/e)
11 Duranta repens Linn. L (c/e)
56 Quercetin -
19 Himatanthus bracteatus (A.DC.) Woodson L (c/e)
20 Ipomoea purga (Wender.) Hayne S (e)
21 L (e)
28 Ixora coccinea Linn. F (c/e)
57 Mixture of α- and β-amyrin -
29 Mabea piriri Aubl. S (e)
37 Ocotea longifolia Kunth (Oreodaphne opifera Mart. Nees) L (e)




aParts of the plant: L leaves, S stem, and F Fruits
bExtractions: h hexane, m methanol, e ethanol, m/e methanol/H2O partition from th
hexane partition from the ethanolic extract, c/e chloroform partition from the ethan
ethanolic extract
cTumor cells: B16-F10 (mouse melanoma), HepG2 (human hepatocellular carcinoma
leukemia). Non-tumor cells: PBMC (human peripheral blood mononuclear cells activ
dData are presented as IC50 values in μg/mL and their 95 % confidence interval obt
in duplicate, measured using alamar blue assay after 72 h incubation. The negative
eDoxorubicin was used as the positive controlnon-tumor cells (PBMC) for the extracts that caused
more than 75 % cell growth inhibition (Table 3). In
addition, the chloroform soluble fractions of D. repens
flowers and the hexane extract I. coccinea flowers iso-
lated quercetin and the mixture of α- and β-amyrin
(Fig. 1), respectively, which were also tested for their
cytotoxic activity (Table 3).ds against tumor cell lines
Cellsc (IC50 in μg/mL)d
B16-F10 HepG2 HL60 K562 PBMC
13.46 27.95 32.56 >50 33.81
10.47–17.30 20.79–37.60 25.44–41.66 26.45–43.23
17.44 41.53 28.21 >50 >50
13.95–21.81 35.31–48.85 21.18–37.57
16.89 26.19 16.14 28.32 17.58
14.63–19.49 23.14–29.64 13.85–18.82 16.96–47.29 10.01–30.86
29.00 33.78 22.41 21.12 >50
24.51–34.30 29.44–38.75 14.10–35.62 17.77–25.11
12.12 12.15 8.81 14.93 14.39
9.92–14.81 9.82–15.05 7.28–10.65 13.90–16.04 11.18–18.52
22.43 24.75 23.06 29.85 12.53
20.80–24.18 21.70–28.22 20.62–25.79 26.87–33.15 8.28–18.96
7.39 8.52 9.39 8.53 6.99
6.03–9.07 7.51–9.65 7.81–11.30 7.61–9.56 4.43–11.02
16.30 29.63 32.64 28.95 30.71
11.80–22.51 25.59–34.31 28.15–37.85 24.39–34.36 24.04–39.24
40.41 38.25 36.92 >50 >50
36.60–44.63 30.46–48.04 33.52–40.67
23.21 24.09 >25 >25 Nd
18.51–29.11 18.71–31.01
17.76 32.98 22.72 21.89 >50
13.42–23.51 27.61–39.40 13.26–38.91 15.52–30.87
37.07 37.34 31.00 43.34 21.06
32.10–42.81 31.34–44.49 21.04–45.69 39.47–47.58 17.48–25.37
15.58 18.32 18.91 31.38 12.73
11.29–21.51 14.91–22.50 13.93–25.67 22.78–43.22 7.43–21.81
27.06 37.06 36.06 16.45 29.14
19.26–38.02 31.54–43.53 28.65–45.40 13.16–20.56 22.46–37.82
0.08 0.03 0.02 0.06 0.14
0.06–0.11 0.02–0.03 0.02–0.02 0.04–0.09 0.02–1.08
e ethanolic extract, ea/e ethyl acetate partition from the ethanolic extract, h/e
olic extract, h:ea/e hexane:ethyl acetate (1:1) partition from the
), HL-60 (human promyelocytic leukemia) and K562 (human chronic myelocytic
ated with concanavalin A – human lymphoblast)
ained by nonlinear regression from three independent experiments performed
control received the vehicle used to dilute the tested samples (0.5 % DMSO)
56 
57 
Fig 1 The chemical structures of quercetin (56) isolated from the chloroform soluble fractions of Duranta repens flowers and α- and β-amyrin (57)
isolated from the hexane extract of Ixora coccinea flowers
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used in this work, which is based in the United States
National Cancer Institute program, only those extracts
that present IC50 values below 30 μg/mL and pure com-
pounds with IC50 values below 4 μg/mL in tumor cell
line assays are considered to be promising for anticancer
drug development [9–11]. Therefore, the B. sericea, D.
repens, H. bracteatus, I. purga, I. coccinea, M. piriri, O.
longifolia and P. capitata extracts demonstrated promising
cytotoxic activity. Doxorubicin, a clinical useful chemother-
apy drug, was used as the positive control and presented
IC50 values ranged from 0.02 to 0.08 μg/mL for HL-60 and
B16-F10, respectively.
The pharmacology activity of B. sericea has been pre-
viously reported; the ethanolic extract from its leaves
has gastroprotective properties that are mediated by ni-
tric oxide and the K+ ATP channel. Phytochemical stud-
ies have revealed the presence of flavonoids (i.e., rutin,
isoquercitrin, kaempferol 3-O-rutinoside and quercetin).
However, its cytotoxic activity has not been previously
reported [12]. Previous studies of D. repens have re-
ported the presence of triterpenes, flavonoids, steroids,
C-alkylated flavonoids and acetosides, as well as some al-
kaloids. Interestingly, durantanin IV and V and E/Z
acteoside isolated from the leaves of D. repens have dem-
onstrated significant cytotoxic activity against a HepG2
cell line [13]. Jalapinoside, a macrocyclic bisdesmosideresin glycoside, was recently isolated from the roots of I.
purga, and its cytotoxic activity was evaluated. Jalapino-
side was not cytotoxic (IC50 > 10 μg/mL), but reversal of
multidrug resistance was observed using vinblastine-
resistant human breast carcinoma cells [14]. In this
study, we isolated the flavonol quercetin from the
flowers of D. repens, which demonstrated a cytotoxic ef-
fect (with IC50 values ranging from 8.81 to 14.93 μg/mL
on tumor cell lines HL-60 and K562, respectively).
Quercetin has been previously reported as a cytotoxic
agent because of its ability to induce apoptosis [15, 16].
The antitumor activity of flowers of I. coccinea was previ-
ously studied in murine models. Inhibited tumor growth
and increased life spans were observed in Dalton’s lymph-
oma and Ehrlich ascites carcinoma-bearing mice [17].
Moreover, ixorapeptide I, a peptide derived from I. cocci-
nea, displayed cytotoxicity against the Hep3B liver tumor
cell line, with an IC50 value of 3.36 μg/mL [18]. Interestedly,
although the use of I. coccinea is currently only ornamental
in Brazil, its flowers are an ingredient in an Ayurvedic can-
cer formulation in India [19, 20]. The flowers of I. coccinea
are used to treat cancer, leucorrhoea, dysentery, dysmenor-
rhea, hemoptysis and hypertension; its leaves are used to
pacify vitiated pitta, skin diseases, colic, flatulence, diarrhea,
indigestion, ulcers and wounds, and they are also used as
an antiseptic [20, 21]. The roots of I. coccinea are used as
an astringent and antiseptic against scabies and other skin
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of I. coccinea flowers resulted in the mixture of α- and β-
amyrin, which demonstrated weak cytotoxic activity toward
tumor cell lines. In fact, no potent cytotoxic activity has
been reported for these compounds.
Prieto et al. [22] have reported that essential oil from
the leaves of O. longifolia, of which α-terpinolene and α-
phellandrene are the primary ingredients, demonstrates
antifungal activity against Sitophilus zeamais. However,
the cytotoxic activity of the O. longifolia plant has not
been previously reported. No previous biological effects
have been reported for the medicinal plants H. bractea-
tus, M. piriri and P. capitata.
The extracts from C. impressinervia, H. tomentosa, M.
minutiflora, M. charantia, O. glomerata, P. fruticosa, S.
morototoni, S. paludosum, X. frutescens and Z. rhoifo-
lium showed no pronounced cytotoxic effects. Among
these plants, essential oil from the leaves of X. frutescens
has been previously assessed for its cytotoxic and antitu-
mor effects; the oil demonstrated potent in vitro cyto-
toxic activity against tumor cell lines from different
histotypes and in vivo antitumor activity in sarcoma 180
murine model [23]. Although essential oil from Z.
rhoifolium leaves and M. charantia fruit extract have
been previously assessed for cytotoxicity, they demon-
strated no cytotoxic effects [24, 25]. The cytotoxic poten-
tial of C. impressinervia, H. tomentosa, M. minutiflora, O.
glomerata, P. fruticose, S. morototoni and S. paludosum
plants has never been investigated.
Conclusion
In conclusion, we screened the cytotoxic potential of 55
extracts from 18 plants found in northeast Brazil, and
extracts from B. sericea, D. repens, H. bracteatus, I.
purga, I. coccinea, M. piriri, O. longifolia and P. capitata
demonstrated potent cytotoxic effects. The fractionation
of D. repens and I. coccinea extracts led to the isolation
of quercetin and the mixture of α- and β-amyrin, re-
spectively, and quercetin showed moderate cytotoxic
activity. Fractionation of the other plants should be per-
formed to identify their active constituents, and further
investigations are required to determine their mecha-
nisms of cytotoxicity and in vivo activities. This work
reinforces the need to understand the therapeutic
potentialities of Brazilian medicinal plants.
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